RMIT and MGC Pharmaceuticals Sign Strategic Agreement
Filed with ASX · · 3 pages · English
Earlier from Argent Biopharma
- Botanical Division Update - Europe and Australia
- First European Distribution Deal Signed for API Products
- EU Medical Cannabis License Granted with Strategic Agreement
- Positive MGC Derma Clinical Test Results
- CEO Appointment
Later from Argent Biopharma
- Appendix 4E and Audited 2017 Financial Report
- Major EU Pharma Supply Agreement Signed with Lenis
- MXC Botanic Division Operational Update
- $40 Million White-Label CBD Cosmetics Agreement Executed
- First $8m Binding Cosmetics Sales Agreement Signed
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma